Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH) ) is now available.
On September 11, 2025, Joseph Tung resigned from his position as a director of Shuttle Pharmaceuticals Holdings, Inc. His resignation was not due to any disagreements requiring disclosure, indicating a smooth transition for the company.
Spark’s Take on SHPH Stock
According to Spark, TipRanks’ AI Analyst, SHPH is a Underperform.
Shuttle Pharmaceuticals Holdings, Inc. faces significant financial challenges with no revenue and ongoing cash burn. Technical indicators show bearish trends, and valuation metrics highlight the company’s unprofitability. While recent corporate activities offer potential strategic benefits, they also add financial strain and governance complexities, leading to an overall low stock score.
To see Spark’s full report on SHPH stock, click here.
More about Shuttle Pharmaceuticals Holdings, Inc.
Average Trading Volume: 108,176
Technical Sentiment Signal: Sell
Current Market Cap: $3.72M
See more insights into SHPH stock on TipRanks’ Stock Analysis page.